canyon landscape

BHV-3241 in Subjects with Multiple System Atrophy

Home / Patient Care / Take Action / Find a Clinical Trial / Clinical Trials / BHV-3241 in Subjects with Multiple System Atrophy
The purpose of this study is to compare the efficacy of BHV-3241 versus placebo in subjects with multiple system atrophy.
Status
Open and enrolling subjects.
Location
Phoenix, Arizona
Age Range
  • 40-75
Total Participants
250
Keywords
Primary Sponsor
Biohaven Pharmaceuticals, Inc.